Why the study?
Nucleoporins regulate pluripotent biology, but the mechanisms by which they do so remain partially characterized.
Disruption of the nup155 gene in mouse embryonic stem cells leads to downregulation of the miR290-295 cluster and core pluripotency factors, suggesting a mechanism by which nucleoporins regulate pluripotency in a pro-arrhythmogenic background.
Nucleoporins have been reported to regulate pluripotent biology, but how they do so remains partially characterized. This study examined the effects of nup155 gene disruption on mouse embryonic stem cells to gain insights into possible mechanisms by which nucleoporins regulate pluripotency in a pro-arrhythmogenic stem cell line. Embryonic stem cells with gene-trapped nup155 exhibited aberrant colony morphology underscored by abnormal transcriptome remodeling. Bioinformatic analysis of whole transcriptome data from nup155 +/− embryonic stem cells revealed changes in a variety of non-coding RNA elements, with significant under expression of miR291a , miR291b , miR293 , and miR294 . These miRNAs are members of the larger regulatory miR290–295 cluster that regulates pluripotency and are controlled by the canonical stem cell-related factors SOX2, OCT4, and NANOG. Expression analysis of these factors revealed downregulation in all three, supported by biochemical profiling and image analysis. These data implicate disruption of the miR -SOX2/OCT4/NANOG regulatory circuit occurs downstream of nup155 gene lesion.
No takes yet. Share an insight, caveat, or question.
Preston et al. (2019) studied NUP155 insufficiency. nup155+/- gene disruption vs. Wild type (WT) ESCs was evaluated on NANOG protein expression (p=<0.01).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: